

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | hemidesmosome assembly (GO:0031581) | 6.41133129 |
| 2 | angiotensin maturation (GO:0002003) | 6.26441188 |
| 3 | desmosome organization (GO:0002934) | 5.67783219 |
| 4 | regulation of guanylate cyclase activity (GO:0031282) | 5.14495082 |
| 5 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.13150913 |
| 6 | cellular response to vitamin D (GO:0071305) | 4.45970806 |
| 7 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.30809571 |
| 8 | cellular response to vitamin (GO:0071295) | 3.94368592 |
| 9 | NADH metabolic process (GO:0006734) | 3.93191169 |
| 10 | urate metabolic process (GO:0046415) | 3.92865939 |
| 11 | regulation of cellular extravasation (GO:0002691) | 3.84669680 |
| 12 | renal system process involved in regulation of blood volume (GO:0001977) | 3.81582892 |
| 13 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.80388523 |
| 14 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.80388523 |
| 15 | endocrine process (GO:0050886) | 3.80388523 |
| 16 | epoxygenase P450 pathway (GO:0019373) | 3.79457921 |
| 17 | positive regulation of pseudopodium assembly (GO:0031274) | 3.69833234 |
| 18 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.58932860 |
| 19 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.58490257 |
| 20 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.57669788 |
| 21 | drug transmembrane transport (GO:0006855) | 3.57039055 |
| 22 | actin filament depolymerization (GO:0030042) | 3.56400664 |
| 23 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.53122504 |
| 24 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.52775022 |
| 25 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.51098327 |
| 26 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.47916972 |
| 27 | lipoprotein transport (GO:0042953) | 3.44018999 |
| 28 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.43784029 |
| 29 | drug transport (GO:0015893) | 3.39197070 |
| 30 | regulation of vitamin metabolic process (GO:0030656) | 3.38791119 |
| 31 | renal absorption (GO:0070293) | 3.38220549 |
| 32 | regulation of systemic arterial blood pressure (GO:0003073) | 3.37138736 |
| 33 | negative regulation of osteoblast proliferation (GO:0033689) | 3.34529074 |
| 34 | cellular glucuronidation (GO:0052695) | 3.27388745 |
| 35 | fructose metabolic process (GO:0006000) | 3.25730495 |
| 36 | regulation of pseudopodium assembly (GO:0031272) | 3.24747996 |
| 37 | bile acid and bile salt transport (GO:0015721) | 3.24176480 |
| 38 | chondrocyte proliferation (GO:0035988) | 3.23679455 |
| 39 | glomerular filtration (GO:0003094) | 3.19875015 |
| 40 | epithelial structure maintenance (GO:0010669) | 3.11116734 |
| 41 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.10939901 |
| 42 | glucuronate metabolic process (GO:0019585) | 3.10615569 |
| 43 | uronic acid metabolic process (GO:0006063) | 3.10615569 |
| 44 | glycosphingolipid catabolic process (GO:0046479) | 2.99471169 |
| 45 | wound healing, spreading of epidermal cells (GO:0035313) | 2.98952362 |
| 46 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.98697189 |
| 47 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.96958366 |
| 48 | virion attachment to host cell (GO:0019062) | 2.96503934 |
| 49 | adhesion of symbiont to host cell (GO:0044650) | 2.96503934 |
| 50 | skin morphogenesis (GO:0043589) | 2.96273721 |
| 51 | regulation of cGMP biosynthetic process (GO:0030826) | 2.95811807 |
| 52 | adhesion of symbiont to host (GO:0044406) | 2.95377575 |
| 53 | sulfate transmembrane transport (GO:1902358) | 2.95082483 |
| 54 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.94361251 |
| 55 | positive regulation of cartilage development (GO:0061036) | 2.92098811 |
| 56 | diacylglycerol metabolic process (GO:0046339) | 2.91975944 |
| 57 | regulation of bile acid biosynthetic process (GO:0070857) | 2.90329504 |
| 58 | regulation of extracellular matrix disassembly (GO:0010715) | 2.89637713 |
| 59 | glycolipid catabolic process (GO:0019377) | 2.89468686 |
| 60 | drug catabolic process (GO:0042737) | 2.89312177 |
| 61 | metanephric tubule development (GO:0072170) | 2.88305084 |
| 62 | metanephric nephron tubule development (GO:0072234) | 2.88305084 |
| 63 | positive regulation of respiratory burst (GO:0060267) | 2.87166805 |
| 64 | metanephric nephron epithelium development (GO:0072243) | 2.86971429 |
| 65 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.86592717 |
| 66 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.86592717 |
| 67 | regulation of cholesterol homeostasis (GO:2000188) | 2.85507172 |
| 68 | wound healing, spreading of cells (GO:0044319) | 2.84746739 |
| 69 | sphingomyelin metabolic process (GO:0006684) | 2.84598827 |
| 70 | COPI coating of Golgi vesicle (GO:0048205) | 2.82846096 |
| 71 | Golgi transport vesicle coating (GO:0048200) | 2.82846096 |
| 72 | drug metabolic process (GO:0017144) | 2.78053589 |
| 73 | phospholipid scrambling (GO:0017121) | 2.77909100 |
| 74 | peptide hormone processing (GO:0016486) | 2.77763207 |
| 75 | O-glycan processing (GO:0016266) | 2.77689258 |
| 76 | flavonoid metabolic process (GO:0009812) | 2.76250171 |
| 77 | auditory receptor cell differentiation (GO:0042491) | 2.74994966 |
| 78 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.74390860 |
| 79 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.71275584 |
| 80 | modified amino acid transport (GO:0072337) | 2.69333104 |
| 81 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.68885123 |
| 82 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.68883005 |
| 83 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.68562502 |
| 84 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.68362714 |
| 85 | phosphate ion transport (GO:0006817) | 2.67781218 |
| 86 | detection of other organism (GO:0098543) | 2.66153299 |
| 87 | metanephric epithelium development (GO:0072207) | 2.65394733 |
| 88 | organic cation transport (GO:0015695) | 2.65170135 |
| 89 | positive regulation of lipid catabolic process (GO:0050996) | 2.62623921 |
| 90 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.62308309 |
| 91 | digestive system process (GO:0022600) | 2.62090754 |
| 92 | hormone catabolic process (GO:0042447) | 2.61631423 |
| 93 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.60817570 |
| 94 | nephron tubule development (GO:0072080) | 2.60534797 |
| 95 | cell-substrate junction assembly (GO:0007044) | 2.60490124 |
| 96 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.59396787 |
| 97 | epithelial cell-cell adhesion (GO:0090136) | 2.58439159 |
| 98 | detection of bacterium (GO:0016045) | 2.58216900 |
| 99 | cysteine metabolic process (GO:0006534) | 2.57333095 |
| 100 | cGMP-mediated signaling (GO:0019934) | 2.56094443 |
| 101 | cellular response to nutrient (GO:0031670) | 2.55167382 |
| 102 | atrioventricular valve morphogenesis (GO:0003181) | 2.54656607 |
| 103 | collagen fibril organization (GO:0030199) | 2.53522241 |
| 104 | transcytosis (GO:0045056) | 2.53306735 |
| 105 | cell adhesion mediated by integrin (GO:0033627) | 2.52680257 |
| 106 | peptide catabolic process (GO:0043171) | 2.51998516 |
| 107 | endothelial cell morphogenesis (GO:0001886) | 2.50317293 |
| 108 | regulation of osteoblast proliferation (GO:0033688) | 2.49888750 |
| 109 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.48946577 |
| 110 | keratinocyte proliferation (GO:0043616) | 2.47970368 |
| 111 | labyrinthine layer development (GO:0060711) | 2.47166578 |
| 112 | intestinal absorption (GO:0050892) | 2.47083142 |
| 113 | sphingolipid catabolic process (GO:0030149) | 2.46201443 |
| 114 | digestion (GO:0007586) | 2.45835072 |
| 115 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.45671232 |
| 116 | urea cycle (GO:0000050) | 2.45547367 |
| 117 | alkaloid metabolic process (GO:0009820) | 2.45255231 |
| 118 | regulation of respiratory burst (GO:0060263) | 2.44994150 |
| 119 | antimicrobial humoral response (GO:0019730) | 2.44199300 |
| 120 | leukotriene metabolic process (GO:0006691) | 2.44083122 |
| 121 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.43954336 |
| 122 | regulation of cGMP metabolic process (GO:0030823) | 2.42494956 |
| 123 | cholesterol catabolic process (GO:0006707) | 2.42341062 |
| 124 | sterol catabolic process (GO:0016127) | 2.42341062 |
| 125 | macroautophagy (GO:0016236) | 2.42030778 |
| 126 | positive regulation of collagen biosynthetic process (GO:0032967) | 2.41437643 |
| 127 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.41245317 |
| 128 | collecting duct development (GO:0072044) | 2.40852127 |
| 129 | polyol transport (GO:0015791) | 2.40625858 |
| 130 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.40449013 |
| 131 | renal tubule development (GO:0061326) | 2.40330695 |
| 132 | homocysteine metabolic process (GO:0050667) | 2.38750456 |
| 133 | antibacterial humoral response (GO:0019731) | 2.38144949 |
| 134 | protein retention in ER lumen (GO:0006621) | 2.36279360 |
| 135 | ethanol oxidation (GO:0006069) | 2.35862566 |
| 136 | tricarboxylic acid metabolic process (GO:0072350) | 2.35165743 |
| 137 | ceramide catabolic process (GO:0046514) | 2.34267757 |
| 138 | urea metabolic process (GO:0019627) | 2.34257269 |
| 139 | apoptotic cell clearance (GO:0043277) | 2.34148473 |
| 140 | sulfur amino acid catabolic process (GO:0000098) | 2.34112784 |
| 141 | intracellular lipid transport (GO:0032365) | 2.33809772 |
| 142 | glucocorticoid biosynthetic process (GO:0006704) | 2.33460036 |
| 143 | membrane lipid catabolic process (GO:0046466) | 2.33276344 |
| 144 | oligosaccharide biosynthetic process (GO:0009312) | 2.32675512 |
| 145 | thrombin receptor signaling pathway (GO:0070493) | 2.32212453 |
| 146 | fibril organization (GO:0097435) | 2.31512356 |
| 147 | nephron epithelium development (GO:0072009) | 2.31502893 |
| 148 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.30976057 |
| 149 | response to vitamin D (GO:0033280) | 2.30939497 |
| 150 | positive regulation of collagen metabolic process (GO:0010714) | 2.30279545 |
| 151 | quaternary ammonium group transport (GO:0015697) | 2.30020276 |
| 152 | negative regulation of myotube differentiation (GO:0010832) | 2.29884044 |
| 153 | glycosylceramide metabolic process (GO:0006677) | 2.29707615 |
| 154 | toxin metabolic process (GO:0009404) | 2.29368171 |
| 155 | positive regulation of chondrocyte differentiation (GO:0032332) | 2.29037557 |
| 156 | sulfate transport (GO:0008272) | 2.28832939 |
| 157 | excretion (GO:0007588) | 2.28789569 |
| 158 | response to laminar fluid shear stress (GO:0034616) | 2.28595783 |
| 159 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.28553690 |
| 160 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.27702886 |
| 161 | citrulline biosynthetic process (GO:0019240) | 2.26773271 |
| 162 | exogenous drug catabolic process (GO:0042738) | 2.26041900 |
| 163 | lysine metabolic process (GO:0006553) | 2.25634979 |
| 164 | lysine catabolic process (GO:0006554) | 2.25634979 |
| 165 | endodermal cell differentiation (GO:0035987) | 2.25003968 |
| 166 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.24662875 |
| 167 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.24382052 |
| 168 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.24355087 |
| 169 | renal filtration (GO:0097205) | 2.24335604 |
| 170 | regulation of water loss via skin (GO:0033561) | 2.23042196 |
| 171 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.22647572 |
| 172 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.20653100 |
| 173 | glutathione biosynthetic process (GO:0006750) | 2.19342854 |
| 174 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.19284025 |
| 175 | toxin transport (GO:1901998) | 2.19173318 |
| 176 | regulation of collagen biosynthetic process (GO:0032965) | 2.18574943 |
| 177 | multicellular organismal water homeostasis (GO:0050891) | 2.18220154 |
| 178 | amino-acid betaine transport (GO:0015838) | 2.17227263 |
| 179 | carnitine transport (GO:0015879) | 2.17227263 |
| 180 | regulation of collagen metabolic process (GO:0010712) | 2.14940153 |
| 181 | phosphate ion transmembrane transport (GO:0035435) | 2.14752087 |
| 182 | lipoprotein metabolic process (GO:0042157) | 2.13239649 |
| 183 | cellular modified amino acid catabolic process (GO:0042219) | 2.13170226 |
| 184 | positive regulation of gastrulation (GO:2000543) | 2.13148708 |
| 185 | membrane budding (GO:0006900) | 2.12796879 |
| 186 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.12580310 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.35033951 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.85433692 |
| 3 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.43802117 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.79480459 |
| 5 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.76334377 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.67076790 |
| 7 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.57222183 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.44288264 |
| 9 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.35163366 |
| 10 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.24234594 |
| 11 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.24032685 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.20307210 |
| 13 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 2.11844722 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.05299483 |
| 15 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.04856998 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.03807239 |
| 17 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.03545654 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.01756591 |
| 19 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.99664453 |
| 20 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.90918965 |
| 21 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.90042484 |
| 22 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.83982076 |
| 23 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.83107561 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.81477404 |
| 25 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.80428839 |
| 26 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.79107566 |
| 27 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.78196819 |
| 28 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.70482676 |
| 29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66560669 |
| 30 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.63306813 |
| 31 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.62257139 |
| 32 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.62257139 |
| 33 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.57611310 |
| 34 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.56398984 |
| 35 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.55792840 |
| 36 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53957698 |
| 37 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.52180974 |
| 38 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.51256942 |
| 39 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.48270294 |
| 40 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.46483061 |
| 41 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.45552066 |
| 42 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.45552066 |
| 43 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.45551722 |
| 44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.44291423 |
| 45 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.42208312 |
| 46 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.41897562 |
| 47 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.41608526 |
| 48 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40793064 |
| 49 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.39926848 |
| 50 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.37112927 |
| 51 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.36449822 |
| 52 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.35652494 |
| 53 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.35481723 |
| 54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.33662574 |
| 55 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.33538339 |
| 56 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.29707410 |
| 57 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.26966005 |
| 58 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26669447 |
| 59 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.26608393 |
| 60 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.24571626 |
| 61 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23376217 |
| 62 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.22278781 |
| 63 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.21742181 |
| 64 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21515745 |
| 65 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.20826204 |
| 66 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.20463308 |
| 67 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18979787 |
| 68 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.18863130 |
| 69 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.18605352 |
| 70 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.17970775 |
| 71 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17927672 |
| 72 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.17891224 |
| 73 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.17834814 |
| 74 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.16525099 |
| 75 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13521875 |
| 76 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.13430801 |
| 77 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.13255880 |
| 78 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.10856883 |
| 79 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.09357486 |
| 80 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.09255271 |
| 81 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.09006922 |
| 82 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.08730849 |
| 83 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08587413 |
| 84 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07741452 |
| 85 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.07702530 |
| 86 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.06419169 |
| 87 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.05827054 |
| 88 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.04458148 |
| 89 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03845867 |
| 90 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03606466 |
| 91 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03218242 |
| 92 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.01412153 |
| 93 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01006965 |
| 94 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01001316 |
| 95 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.00327094 |
| 96 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00160934 |
| 97 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.99700714 |
| 98 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.99525134 |
| 99 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.99207489 |
| 100 | RXR_22108803_ChIP-Seq_LS180_Human | 0.98673185 |
| 101 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97484681 |
| 102 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.97330442 |
| 103 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.97330442 |
| 104 | SPI1_23127762_ChIP-Seq_K562_Human | 0.97212876 |
| 105 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.96912888 |
| 106 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.96582029 |
| 107 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.96062913 |
| 108 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.95645010 |
| 109 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95490637 |
| 110 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.95476903 |
| 111 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.95230821 |
| 112 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.94857765 |
| 113 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.94382142 |
| 114 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.92925220 |
| 115 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92727357 |
| 116 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.92223873 |
| 117 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.91470933 |
| 118 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91396348 |
| 119 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.90018851 |
| 120 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89697345 |
| 121 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.89353547 |
| 122 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.89353547 |
| 123 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.89092752 |
| 124 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.88906960 |
| 125 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.88678062 |
| 126 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.88433375 |
| 127 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.87798150 |
| 128 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.87621036 |
| 129 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.87370322 |
| 130 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.87246002 |
| 131 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87220202 |
| 132 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.86898008 |
| 133 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.86534274 |
| 134 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.86169377 |
| 135 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.85231352 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 3.96760241 |
| 2 | MP0005360_urolithiasis | 3.31949366 |
| 3 | MP0003183_abnormal_peptide_metabolism | 3.12146693 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.11331648 |
| 5 | MP0005275_abnormal_skin_tensile | 2.72577959 |
| 6 | MP0010155_abnormal_intestine_physiology | 2.60164029 |
| 7 | MP0008438_abnormal_cutaneous_collagen | 2.53967978 |
| 8 | MP0003866_abnormal_defecation | 2.49770711 |
| 9 | MP0002060_abnormal_skin_morphology | 2.31811456 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.30424204 |
| 11 | MP0010352_gastrointestinal_tract_polyps | 2.28548470 |
| 12 | MP0003941_abnormal_skin_development | 2.26924822 |
| 13 | MP0000383_abnormal_hair_follicle | 2.21639978 |
| 14 | MP0002796_impaired_skin_barrier | 2.17662081 |
| 15 | MP0004272_abnormal_basement_membrane | 2.17618704 |
| 16 | MP0002254_reproductive_system_inflammat | 2.16281698 |
| 17 | MP0005409_darkened_coat_color | 2.14138833 |
| 18 | MP0004043_abnormal_pH_regulation | 2.12685324 |
| 19 | MP0003252_abnormal_bile_duct | 2.09280110 |
| 20 | MP0005503_abnormal_tendon_morphology | 2.08212629 |
| 21 | MP0003724_increased_susceptibility_to | 2.06345167 |
| 22 | MP0002139_abnormal_hepatobiliary_system | 2.05333738 |
| 23 | MP0002877_abnormal_melanocyte_morpholog | 2.03324771 |
| 24 | MP0009379_abnormal_foot_pigmentation | 2.03213972 |
| 25 | MP0010678_abnormal_skin_adnexa | 1.99076722 |
| 26 | MP0004019_abnormal_vitamin_homeostasis | 1.95940353 |
| 27 | MP0009384_cardiac_valve_regurgitation | 1.93759791 |
| 28 | MP0002098_abnormal_vibrissa_morphology | 1.90541838 |
| 29 | MP0003283_abnormal_digestive_organ | 1.90325018 |
| 30 | MP0006054_spinal_hemorrhage | 1.87803291 |
| 31 | MP0001664_abnormal_digestion | 1.84269882 |
| 32 | MP0001958_emphysema | 1.80853049 |
| 33 | MP0009643_abnormal_urine_homeostasis | 1.75004146 |
| 34 | MP0003566_abnormal_cell_adhesion | 1.71706537 |
| 35 | MP0002896_abnormal_bone_mineralization | 1.66190767 |
| 36 | MP0004264_abnormal_extraembryonic_tissu | 1.65378830 |
| 37 | MP0000538_abnormal_urinary_bladder | 1.65305806 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 1.63518340 |
| 39 | MP0005166_decreased_susceptibility_to | 1.62865267 |
| 40 | MP0000477_abnormal_intestine_morphology | 1.56697845 |
| 41 | MP0000013_abnormal_adipose_tissue | 1.56394124 |
| 42 | MP0005377_hearing/vestibular/ear_phenot | 1.54056934 |
| 43 | MP0003878_abnormal_ear_physiology | 1.54056934 |
| 44 | MP0000490_abnormal_crypts_of | 1.53252340 |
| 45 | MP0005332_abnormal_amino_acid | 1.52866305 |
| 46 | MP0006082_CNS_inflammation | 1.51517544 |
| 47 | MP0003195_calcinosis | 1.51043565 |
| 48 | MP0005257_abnormal_intraocular_pressure | 1.50775583 |
| 49 | MP0003436_decreased_susceptibility_to | 1.48202753 |
| 50 | MP0004858_abnormal_nervous_system | 1.47275058 |
| 51 | MP0009780_abnormal_chondrocyte_physiolo | 1.47171559 |
| 52 | MP0001765_abnormal_ion_homeostasis | 1.46936042 |
| 53 | MP0001663_abnormal_digestive_system | 1.46638765 |
| 54 | MP0002138_abnormal_hepatobiliary_system | 1.41834184 |
| 55 | MP0001849_ear_inflammation | 1.41829168 |
| 56 | MP0001756_abnormal_urination | 1.41255136 |
| 57 | MP0001216_abnormal_epidermal_layer | 1.39843741 |
| 58 | MP0003453_abnormal_keratinocyte_physiol | 1.36041170 |
| 59 | MP0008875_abnormal_xenobiotic_pharmacok | 1.34525805 |
| 60 | MP0000579_abnormal_nail_morphology | 1.32693184 |
| 61 | MP0005381_digestive/alimentary_phenotyp | 1.32528143 |
| 62 | MP0005501_abnormal_skin_physiology | 1.32518064 |
| 63 | MP0010030_abnormal_orbit_morphology | 1.30625473 |
| 64 | MP0010771_integument_phenotype | 1.28835012 |
| 65 | MP0008260_abnormal_autophagy | 1.26114442 |
| 66 | MP0009785_altered_susceptibility_to | 1.24551004 |
| 67 | MP0001873_stomach_inflammation | 1.21722521 |
| 68 | MP0003303_peritoneal_inflammation | 1.21437951 |
| 69 | MP0003279_aneurysm | 1.21021504 |
| 70 | MP0000465_gastrointestinal_hemorrhage | 1.20494492 |
| 71 | MP0001666_abnormal_nutrient_absorption | 1.19817303 |
| 72 | MP0001835_abnormal_antigen_presentation | 1.18635194 |
| 73 | MP0005670_abnormal_white_adipose | 1.18140676 |
| 74 | MP0005365_abnormal_bile_salt | 1.17937938 |
| 75 | MP0004147_increased_porphyrin_level | 1.17755733 |
| 76 | MP0000762_abnormal_tongue_morphology | 1.16905014 |
| 77 | MP0004947_skin_inflammation | 1.16875589 |
| 78 | MP0001533_abnormal_skeleton_physiology | 1.16335330 |
| 79 | MP0002136_abnormal_kidney_physiology | 1.14551142 |
| 80 | MP0005058_abnormal_lysosome_morphology | 1.10105822 |
| 81 | MP0000163_abnormal_cartilage_morphology | 1.09794618 |
| 82 | MP0000537_abnormal_urethra_morphology | 1.08667857 |
| 83 | MP0003879_abnormal_hair_cell | 1.08628744 |
| 84 | MP0002166_altered_tumor_susceptibility | 1.07079773 |
| 85 | MP0005451_abnormal_body_composition | 1.06879078 |
| 86 | MP0002998_abnormal_bone_remodeling | 1.05620854 |
| 87 | MP0005025_abnormal_response_to | 1.04825809 |
| 88 | MP0003011_delayed_dark_adaptation | 1.04192128 |
| 89 | MP0000678_abnormal_parathyroid_gland | 1.03850572 |
| 90 | MP0001270_distended_abdomen | 1.03681267 |
| 91 | MP0003942_abnormal_urinary_system | 1.03603386 |
| 92 | MP0000377_abnormal_hair_follicle | 1.03117328 |
| 93 | MP0001845_abnormal_inflammatory_respons | 1.03088590 |
| 94 | MP0008004_abnormal_stomach_pH | 1.02502006 |
| 95 | MP0000467_abnormal_esophagus_morphology | 1.01773782 |
| 96 | MP0009250_abnormal_appendicular_skeleto | 1.01355164 |
| 97 | MP0002295_abnormal_pulmonary_circulatio | 1.00385291 |
| 98 | MP0009053_abnormal_anal_canal | 0.99163181 |
| 99 | MP0001299_abnormal_eye_distance/ | 0.99059404 |
| 100 | MP0002419_abnormal_innate_immunity | 0.97778557 |
| 101 | MP0005508_abnormal_skeleton_morphology | 0.97111926 |
| 102 | MP0005636_abnormal_mineral_homeostasis | 0.96976429 |
| 103 | MP0002115_abnormal_skeleton_extremities | 0.96702586 |
| 104 | MP0005084_abnormal_gallbladder_morpholo | 0.96024411 |
| 105 | MP0002822_catalepsy | 0.95194579 |
| 106 | MP0009840_abnormal_foam_cell | 0.94155697 |
| 107 | MP0000003_abnormal_adipose_tissue | 0.93800322 |
| 108 | MP0005164_abnormal_response_to | 0.93404627 |
| 109 | MP0002234_abnormal_pharynx_morphology | 0.93024174 |
| 110 | MP0005023_abnormal_wound_healing | 0.92281601 |
| 111 | MP0000462_abnormal_digestive_system | 0.91235724 |
| 112 | MP0000647_abnormal_sebaceous_gland | 0.89626703 |
| 113 | MP0010368_abnormal_lymphatic_system | 0.88881237 |
| 114 | MP0000858_altered_metastatic_potential | 0.88726599 |
| 115 | MP0002876_abnormal_thyroid_physiology | 0.87770363 |
| 116 | MP0005623_abnormal_meninges_morphology | 0.87410302 |
| 117 | MP0000249_abnormal_blood_vessel | 0.86726984 |
| 118 | MP0005220_abnormal_exocrine_pancreas | 0.86228947 |
| 119 | MP0000534_abnormal_ureter_morphology | 0.84174286 |
| 120 | MP0002971_abnormal_brown_adipose | 0.84072894 |
| 121 | MP0001177_atelectasis | 0.83751458 |
| 122 | MP0003806_abnormal_nucleotide_metabolis | 0.83503354 |
| 123 | MP0000230_abnormal_systemic_arterial | 0.82611854 |
| 124 | MP0003091_abnormal_cell_migration | 0.82024506 |
| 125 | MP0002118_abnormal_lipid_homeostasis | 0.81617553 |
| 126 | MP0008469_abnormal_protein_level | 0.80729247 |
| 127 | MP0005167_abnormal_blood-brain_barrier | 0.79926066 |
| 128 | MP0002108_abnormal_muscle_morphology | 0.79151301 |
| 129 | MP0002233_abnormal_nose_morphology | 0.78426212 |
| 130 | MP0005387_immune_system_phenotype | 0.78410844 |
| 131 | MP0001790_abnormal_immune_system | 0.78410844 |
| 132 | MP0004782_abnormal_surfactant_physiolog | 0.78132675 |
| 133 | MP0001191_abnormal_skin_condition | 0.78062647 |
| 134 | MP0001348_abnormal_lacrimal_gland | 0.77834407 |
| 135 | MP0003828_pulmonary_edema | 0.77643409 |
| 136 | MP0002168_other_aberrant_phenotype | 0.76615439 |
| 137 | MP0005319_abnormal_enzyme/_coenzyme | 0.75261108 |
| 138 | MP0002909_abnormal_adrenal_gland | 0.74867983 |
| 139 | MP0005085_abnormal_gallbladder_physiolo | 0.74429179 |
| 140 | MP0010329_abnormal_lipoprotein_level | 0.74198119 |
| 141 | MP0003868_abnormal_feces_composition | 0.73766483 |
| 142 | MP0002132_abnormal_respiratory_system | 0.73390209 |
| 143 | MP0000609_abnormal_liver_physiology | 0.73327006 |
| 144 | MP0000427_abnormal_hair_cycle | 0.73316124 |
| 145 | MP0001243_abnormal_dermal_layer | 0.72533150 |
| 146 | MP0003045_fibrosis | 0.72515341 |
| 147 | MP0005390_skeleton_phenotype | 0.72429640 |
| 148 | MP0001944_abnormal_pancreas_morphology | 0.72350629 |
| 149 | MP0003115_abnormal_respiratory_system | 0.71753231 |
| 150 | MP0003385_abnormal_body_wall | 0.71682779 |
| 151 | MP0002006_tumorigenesis | 0.70492037 |
| 152 | MP0000685_abnormal_immune_system | 0.70026917 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Atrophic scars (HP:0001075) | 4.42081726 |
| 2 | Fragile nails (HP:0001808) | 3.88138063 |
| 3 | Eczematoid dermatitis (HP:0000976) | 3.71354515 |
| 4 | Hyperactive renin-angiotensin system (HP:0000841) | 3.60771875 |
| 5 | Ileus (HP:0002595) | 3.55261198 |
| 6 | Chronic diarrhea (HP:0002028) | 3.53115546 |
| 7 | Milia (HP:0001056) | 3.47016640 |
| 8 | Metabolic alkalosis (HP:0200114) | 3.46466599 |
| 9 | Increased circulating renin level (HP:0000848) | 3.46316546 |
| 10 | Right ventricular cardiomyopathy (HP:0011663) | 3.42884103 |
| 11 | Hypokalemic alkalosis (HP:0001949) | 3.36926027 |
| 12 | Decreased circulating renin level (HP:0003351) | 3.31329307 |
| 13 | Abnormality of the distal phalanges of the toes (HP:0010182) | 3.29399618 |
| 14 | Systemic lupus erythematosus (HP:0002725) | 3.19737758 |
| 15 | Abnormality of chloride homeostasis (HP:0011422) | 3.15217888 |
| 16 | Premature rupture of membranes (HP:0001788) | 3.08152489 |
| 17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.02878365 |
| 18 | Onycholysis (HP:0001806) | 3.00153637 |
| 19 | Hemorrhage of the eye (HP:0011885) | 2.92063301 |
| 20 | Protrusio acetabuli (HP:0003179) | 2.91641174 |
| 21 | Broad metatarsal (HP:0001783) | 2.89441857 |
| 22 | Flat acetabular roof (HP:0003180) | 2.80191584 |
| 23 | Gout (HP:0001997) | 2.74021600 |
| 24 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.72994017 |
| 25 | Plantar hyperkeratosis (HP:0007556) | 2.71538801 |
| 26 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.69554070 |
| 27 | Fat malabsorption (HP:0002630) | 2.69487356 |
| 28 | Widely patent fontanelles and sutures (HP:0004492) | 2.64835752 |
| 29 | Cervical subluxation (HP:0003308) | 2.63704163 |
| 30 | Fragile skin (HP:0001030) | 2.63474635 |
| 31 | Hypomagnesemia (HP:0002917) | 2.62394719 |
| 32 | Hydroxyprolinuria (HP:0003080) | 2.54585207 |
| 33 | Abnormality of proline metabolism (HP:0010907) | 2.54585207 |
| 34 | Thin bony cortex (HP:0002753) | 2.54207253 |
| 35 | Malnutrition (HP:0004395) | 2.53232116 |
| 36 | Abnormality of vitamin B metabolism (HP:0004340) | 2.53003610 |
| 37 | Amyloidosis (HP:0011034) | 2.52643322 |
| 38 | Congenital sensorineural hearing impairment (HP:0008527) | 2.51677916 |
| 39 | Abnormality of renin-angiotensin system (HP:0000847) | 2.49675606 |
| 40 | Proximal tubulopathy (HP:0000114) | 2.49454861 |
| 41 | Villous atrophy (HP:0011473) | 2.48145775 |
| 42 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.48145775 |
| 43 | Gingivitis (HP:0000230) | 2.46251651 |
| 44 | Polyuria (HP:0000103) | 2.45796316 |
| 45 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.45635046 |
| 46 | Neonatal short-limb short stature (HP:0008921) | 2.44467109 |
| 47 | Abnormal urine output (HP:0012590) | 2.40895457 |
| 48 | Hyperparathyroidism (HP:0000843) | 2.40876083 |
| 49 | Abnormal tarsal ossification (HP:0008369) | 2.38228666 |
| 50 | Abnormality of macrophages (HP:0004311) | 2.35351812 |
| 51 | Osteolytic defects of the hand bones (HP:0009699) | 2.34805973 |
| 52 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.34805973 |
| 53 | Conjugated hyperbilirubinemia (HP:0002908) | 2.32925939 |
| 54 | Abnormality of renal excretion (HP:0011036) | 2.31763992 |
| 55 | Vascular tortuosity (HP:0004948) | 2.31127978 |
| 56 | Abnormality of magnesium homeostasis (HP:0004921) | 2.30747846 |
| 57 | Protuberant abdomen (HP:0001538) | 2.30189034 |
| 58 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.29538648 |
| 59 | Aplasia of the phalanges of the hand (HP:0009802) | 2.29538648 |
| 60 | Aplasia involving bones of the extremities (HP:0009825) | 2.29538648 |
| 61 | Confusion (HP:0001289) | 2.28784904 |
| 62 | Hypoplasia of dental enamel (HP:0006297) | 2.28661149 |
| 63 | Arterial tortuosity (HP:0005116) | 2.28525786 |
| 64 | Tetany (HP:0001281) | 2.28505484 |
| 65 | Abdominal distention (HP:0003270) | 2.25890550 |
| 66 | Hypokalemia (HP:0002900) | 2.25324399 |
| 67 | Hyperaldosteronism (HP:0000859) | 2.23137854 |
| 68 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.22196999 |
| 69 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.21667974 |
| 70 | Shallow orbits (HP:0000586) | 2.21309044 |
| 71 | Abnormality of carpal bone ossification (HP:0006257) | 2.19598142 |
| 72 | Renal tubular acidosis (HP:0001947) | 2.18584413 |
| 73 | Abnormality of purine metabolism (HP:0004352) | 2.18549506 |
| 74 | Wide cranial sutures (HP:0010537) | 2.18331224 |
| 75 | Ketoacidosis (HP:0001993) | 2.17558606 |
| 76 | Focal segmental glomerulosclerosis (HP:0000097) | 2.12780200 |
| 77 | Cardiovascular calcification (HP:0011915) | 2.12487213 |
| 78 | Abnormality of vitamin metabolism (HP:0100508) | 2.12153465 |
| 79 | Down-sloping shoulders (HP:0200021) | 2.10988132 |
| 80 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.10982438 |
| 81 | Hyperphosphatemia (HP:0002905) | 2.10658761 |
| 82 | Cerebral aneurysm (HP:0004944) | 2.10200921 |
| 83 | Abnormal foot bone ossification (HP:0010675) | 2.09412438 |
| 84 | Hypophosphatemia (HP:0002148) | 2.08699296 |
| 85 | Hypobetalipoproteinemia (HP:0003563) | 2.07988457 |
| 86 | Alkalosis (HP:0001948) | 2.05735379 |
| 87 | Aortic aneurysm (HP:0004942) | 2.05375539 |
| 88 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.04412790 |
| 89 | Increased connective tissue (HP:0009025) | 2.04184310 |
| 90 | Back pain (HP:0003418) | 2.03397374 |
| 91 | Increased purine levels (HP:0004368) | 2.03306875 |
| 92 | Hyperuricemia (HP:0002149) | 2.03306875 |
| 93 | Hyperglycinuria (HP:0003108) | 2.02881539 |
| 94 | Abnormality of the 2nd finger (HP:0004100) | 2.01967621 |
| 95 | Growth hormone excess (HP:0000845) | 2.01715881 |
| 96 | Abnormality of complement system (HP:0005339) | 2.01517254 |
| 97 | Coronal craniosynostosis (HP:0004440) | 1.99523143 |
| 98 | Vascular calcification (HP:0004934) | 1.98680843 |
| 99 | Distal lower limb muscle weakness (HP:0009053) | 1.97531020 |
| 100 | Petechiae (HP:0000967) | 1.97498265 |
| 101 | Alopecia of scalp (HP:0002293) | 1.97238844 |
| 102 | Xanthomatosis (HP:0000991) | 1.95986525 |
| 103 | Gastrointestinal dysmotility (HP:0002579) | 1.95951259 |
| 104 | Hypotension (HP:0002615) | 1.94460977 |
| 105 | Abnormal ossification of hand bones (HP:0005921) | 1.92432173 |
| 106 | Vertebral compression fractures (HP:0002953) | 1.92391316 |
| 107 | Bone pain (HP:0002653) | 1.91165032 |
| 108 | Vacuolated lymphocytes (HP:0001922) | 1.91110216 |
| 109 | Megalencephaly (HP:0001355) | 1.90228479 |
| 110 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.88550127 |
| 111 | Orchitis (HP:0100796) | 1.86529709 |
| 112 | Pili torti (HP:0003777) | 1.86129242 |
| 113 | Late onset (HP:0003584) | 1.84840396 |
| 114 | Renal salt wasting (HP:0000127) | 1.84767410 |
| 115 | Dysostosis multiplex (HP:0000943) | 1.84595439 |
| 116 | Glomerulonephritis (HP:0000099) | 1.84302187 |
| 117 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.83656733 |
| 118 | Premature loss of primary teeth (HP:0006323) | 1.82489774 |
| 119 | Nephritis (HP:0000123) | 1.82198191 |
| 120 | Cheilitis (HP:0100825) | 1.82092729 |
| 121 | Dehydration (HP:0001944) | 1.81855021 |
| 122 | Gastrointestinal infarctions (HP:0005244) | 1.81818078 |
| 123 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.81300378 |
| 124 | Abnormal hand bone ossification (HP:0010660) | 1.80398791 |
| 125 | Aneurysm (HP:0002617) | 1.80178619 |
| 126 | Aortic dissection (HP:0002647) | 1.80064049 |
| 127 | Pterygium (HP:0001059) | 1.80015473 |
| 128 | Abnormal vertebral ossification (HP:0100569) | 1.79452952 |
| 129 | Axonal loss (HP:0003447) | 1.78938837 |
| 130 | Mucopolysacchariduria (HP:0008155) | 1.78753817 |
| 131 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.78753817 |
| 132 | Abnormality of potassium homeostasis (HP:0011042) | 1.77580100 |
| 133 | Myositis (HP:0100614) | 1.76868387 |
| 134 | Femoral bowing (HP:0002980) | 1.76779665 |
| 135 | Turricephaly (HP:0000262) | 1.75777993 |
| 136 | Wormian bones (HP:0002645) | 1.75737261 |
| 137 | Tetraparesis (HP:0002273) | 1.75319450 |
| 138 | Glomerulosclerosis (HP:0000096) | 1.74670847 |
| 139 | Nausea (HP:0002018) | 1.74592423 |
| 140 | Recurrent abscess formation (HP:0002722) | 1.73678722 |
| 141 | Spondylolisthesis (HP:0003302) | 1.73598055 |
| 142 | Abnormal drinking behavior (HP:0030082) | 1.73593209 |
| 143 | Polydipsia (HP:0001959) | 1.73593209 |
| 144 | Ankle contracture (HP:0006466) | 1.73299606 |
| 145 | Recurrent bacterial skin infections (HP:0005406) | 1.73230074 |
| 146 | Ankyloglossia (HP:0010296) | 1.73193736 |
| 147 | Dilatation of the ascending aorta (HP:0005111) | 1.73088126 |
| 148 | Pigmentary retinal degeneration (HP:0001146) | 1.72924048 |
| 149 | Acanthocytosis (HP:0001927) | 1.72727239 |
| 150 | Abnormal hair laboratory examination (HP:0003328) | 1.72714700 |
| 151 | Scapular winging (HP:0003691) | 1.72461033 |
| 152 | Abnormal glucose tolerance (HP:0001952) | 1.71480460 |
| 153 | Mesangial abnormality (HP:0001966) | 1.69692449 |
| 154 | Enlarged epiphyses (HP:0010580) | 1.68856974 |
| 155 | Emphysema (HP:0002097) | 1.68693576 |
| 156 | Nephrolithiasis (HP:0000787) | 1.68454195 |
| 157 | Advanced eruption of teeth (HP:0006288) | 1.67686923 |
| 158 | Pustule (HP:0200039) | 1.67679777 |
| 159 | Abnormal hemoglobin (HP:0011902) | 1.66970066 |
| 160 | Peritonitis (HP:0002586) | 1.66786932 |
| 161 | Tibial bowing (HP:0002982) | 1.66198100 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.63234951 |
| 2 | ACVR1B | 3.55440096 |
| 3 | MST1R | 3.28243487 |
| 4 | WNK4 | 3.19452730 |
| 5 | MAP2K2 | 3.05324186 |
| 6 | TRIB3 | 2.67830037 |
| 7 | LMTK2 | 2.53310519 |
| 8 | MAP3K3 | 2.44433848 |
| 9 | MAP3K2 | 2.43296541 |
| 10 | DDR2 | 2.30515381 |
| 11 | WNK3 | 2.27545801 |
| 12 | RIPK1 | 2.23838276 |
| 13 | MST4 | 2.23443019 |
| 14 | LRRK2 | 2.09425203 |
| 15 | EPHB2 | 2.03393839 |
| 16 | TYK2 | 1.99378226 |
| 17 | EPHA2 | 1.96356600 |
| 18 | TTN | 1.94635084 |
| 19 | MET | 1.84785443 |
| 20 | STK24 | 1.83453531 |
| 21 | PIK3CA | 1.82501466 |
| 22 | LATS1 | 1.79217562 |
| 23 | FER | 1.78580368 |
| 24 | PDGFRA | 1.67058867 |
| 25 | PTK6 | 1.66585166 |
| 26 | SIK1 | 1.66474310 |
| 27 | PTK2 | 1.61505219 |
| 28 | RIPK4 | 1.55296592 |
| 29 | PRPF4B | 1.54873434 |
| 30 | OXSR1 | 1.51705222 |
| 31 | FRK | 1.44951988 |
| 32 | PRKD3 | 1.43428447 |
| 33 | MAP2K1 | 1.36678472 |
| 34 | INSRR | 1.32777177 |
| 35 | MAPKAPK3 | 1.27955599 |
| 36 | MAP3K12 | 1.22628144 |
| 37 | MAP3K1 | 1.20790764 |
| 38 | ZAP70 | 1.19075360 |
| 39 | PKN2 | 1.18829895 |
| 40 | MAPK15 | 1.14300349 |
| 41 | PAK3 | 1.07748600 |
| 42 | IRAK1 | 1.05417916 |
| 43 | CDC42BPA | 1.04988743 |
| 44 | CSK | 1.04890728 |
| 45 | TRPM7 | 1.04603198 |
| 46 | TBK1 | 1.02402866 |
| 47 | EPHA3 | 1.01313168 |
| 48 | EPHB1 | 0.99577345 |
| 49 | BMPR2 | 0.98271647 |
| 50 | DYRK1B | 0.97908574 |
| 51 | MAP3K6 | 0.96043073 |
| 52 | BMX | 0.95993786 |
| 53 | BLK | 0.94992350 |
| 54 | TGFBR2 | 0.94245650 |
| 55 | PRKD2 | 0.92684051 |
| 56 | GRK6 | 0.91031033 |
| 57 | PHKG1 | 0.90244448 |
| 58 | PHKG2 | 0.90244448 |
| 59 | TESK1 | 0.87651299 |
| 60 | BCKDK | 0.86685956 |
| 61 | JAK1 | 0.86391814 |
| 62 | TGFBR1 | 0.85216010 |
| 63 | MAP3K10 | 0.84080525 |
| 64 | FGFR4 | 0.82608555 |
| 65 | HIPK2 | 0.80653881 |
| 66 | MAPK7 | 0.80490666 |
| 67 | ERBB3 | 0.80481399 |
| 68 | IRAK3 | 0.80392355 |
| 69 | TAOK1 | 0.80004339 |
| 70 | PRKG2 | 0.79772756 |
| 71 | WNK1 | 0.78664616 |
| 72 | ROCK1 | 0.78608327 |
| 73 | PAK2 | 0.77485416 |
| 74 | SIK3 | 0.76324169 |
| 75 | NTRK1 | 0.76050079 |
| 76 | STK10 | 0.75429221 |
| 77 | STK38L | 0.74043344 |
| 78 | MAP3K14 | 0.73343154 |
| 79 | YES1 | 0.73258226 |
| 80 | FGFR1 | 0.72956631 |
| 81 | MAP2K6 | 0.72553387 |
| 82 | FGR | 0.71419636 |
| 83 | TIE1 | 0.69965340 |
| 84 | MAP3K13 | 0.69439010 |
| 85 | MAP4K1 | 0.69076407 |
| 86 | ERBB4 | 0.69032440 |
| 87 | IRAK4 | 0.68987733 |
| 88 | TESK2 | 0.68278858 |
| 89 | GSK3A | 0.66708911 |
| 90 | CSF1R | 0.64263420 |
| 91 | PIK3CG | 0.61594509 |
| 92 | STK39 | 0.60667070 |
| 93 | RET | 0.60583826 |
| 94 | NEK9 | 0.59167348 |
| 95 | KSR2 | 0.58202716 |
| 96 | PRKCH | 0.57703620 |
| 97 | STK38 | 0.56825639 |
| 98 | PDGFRB | 0.56297104 |
| 99 | JAK3 | 0.56259556 |
| 100 | PRKD1 | 0.55757704 |
| 101 | PDK1 | 0.55541965 |
| 102 | MAPKAPK2 | 0.55374591 |
| 103 | MATK | 0.54604218 |
| 104 | IRAK2 | 0.54161062 |
| 105 | PTK2B | 0.53894501 |
| 106 | PAK4 | 0.52717387 |
| 107 | PRKAA2 | 0.52077996 |
| 108 | SGK494 | 0.49085535 |
| 109 | SGK223 | 0.49085535 |
| 110 | MAP3K7 | 0.48999953 |
| 111 | MAPK11 | 0.48392100 |
| 112 | CDK19 | 0.48133857 |
| 113 | PRKCE | 0.48102361 |
| 114 | NUAK1 | 0.48067393 |
| 115 | IGF1R | 0.47358678 |
| 116 | ERBB2 | 0.47238329 |
| 117 | LATS2 | 0.47160493 |
| 118 | MYLK | 0.46978166 |
| 119 | DMPK | 0.46887014 |
| 120 | KIT | 0.46404196 |
| 121 | MAP2K3 | 0.46289970 |
| 122 | PDK4 | 0.45911393 |
| 123 | PDK3 | 0.45911393 |
| 124 | ABL2 | 0.45318077 |
| 125 | RPS6KB2 | 0.44545006 |
| 126 | PIM2 | 0.44462258 |
| 127 | KDR | 0.43903690 |
| 128 | CAMK2D | 0.42841924 |
| 129 | PRKCI | 0.42333824 |
| 130 | JAK2 | 0.42054784 |
| 131 | MOS | 0.41095554 |
| 132 | SGK3 | 0.40488929 |
| 133 | BCR | 0.40371794 |
| 134 | STK3 | 0.40194313 |
| 135 | TNIK | 0.39608470 |
| 136 | SRC | 0.39350764 |
| 137 | ADRBK1 | 0.38822483 |
| 138 | FGFR3 | 0.38773655 |
| 139 | ILK | 0.37851819 |
| 140 | PDK2 | 0.37704953 |
| 141 | IKBKE | 0.37332978 |
| 142 | FYN | 0.36995773 |
| 143 | MARK3 | 0.36650690 |
| 144 | PDPK1 | 0.36009985 |
| 145 | ROCK2 | 0.33261523 |
| 146 | NLK | 0.32515146 |
| 147 | BRAF | 0.32235966 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.72125016 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.70671188 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.39951160 |
| 4 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.26169451 |
| 5 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.23416054 |
| 6 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.19418145 |
| 7 | Mineral absorption_Homo sapiens_hsa04978 | 2.18904400 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.08284556 |
| 9 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.05322422 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.01783572 |
| 11 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.00574118 |
| 12 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.98730370 |
| 13 | Bile secretion_Homo sapiens_hsa04976 | 1.73618258 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.73593289 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.66614305 |
| 16 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.66229446 |
| 17 | Bladder cancer_Homo sapiens_hsa05219 | 1.57803454 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.54936757 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.48722716 |
| 20 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.44766902 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.40556564 |
| 22 | Other glycan degradation_Homo sapiens_hsa00511 | 1.35569266 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 1.34728291 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.31824800 |
| 25 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.30346843 |
| 26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.29444352 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.27511614 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.23661280 |
| 29 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.22119569 |
| 30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.21605077 |
| 31 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.19439173 |
| 32 | Focal adhesion_Homo sapiens_hsa04510 | 1.18598035 |
| 33 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.14995609 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.11800017 |
| 35 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.11112334 |
| 36 | Leishmaniasis_Homo sapiens_hsa05140 | 1.08999102 |
| 37 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.07707798 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.07110078 |
| 39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.06687530 |
| 40 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.05480280 |
| 41 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.01961265 |
| 42 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.01917499 |
| 43 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.01286157 |
| 44 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.99045059 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.96947643 |
| 46 | Histidine metabolism_Homo sapiens_hsa00340 | 0.95043117 |
| 47 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.94648120 |
| 48 | Amoebiasis_Homo sapiens_hsa05146 | 0.93877650 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.92954383 |
| 50 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.92320739 |
| 51 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.91898448 |
| 52 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.91757808 |
| 53 | Adherens junction_Homo sapiens_hsa04520 | 0.91732639 |
| 54 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.90951158 |
| 55 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.90631196 |
| 56 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.90464714 |
| 57 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.90022053 |
| 58 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.89648970 |
| 59 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.88638237 |
| 60 | Lysosome_Homo sapiens_hsa04142 | 0.88599519 |
| 61 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.85779572 |
| 62 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.84498246 |
| 63 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.83746212 |
| 64 | Asthma_Homo sapiens_hsa05310 | 0.82263006 |
| 65 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.80059689 |
| 66 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.79291595 |
| 67 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.79204540 |
| 68 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.79078922 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.77559340 |
| 70 | Hepatitis C_Homo sapiens_hsa05160 | 0.76618715 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.76210057 |
| 72 | Tight junction_Homo sapiens_hsa04530 | 0.76124605 |
| 73 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.75219844 |
| 74 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.75202051 |
| 75 | Allograft rejection_Homo sapiens_hsa05330 | 0.75195845 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.74665730 |
| 77 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.73780590 |
| 78 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.73305053 |
| 79 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.73163406 |
| 80 | ABC transporters_Homo sapiens_hsa02010 | 0.72627275 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.72099778 |
| 82 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.70474100 |
| 83 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.70031751 |
| 84 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.69506928 |
| 85 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.69029101 |
| 86 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.68790049 |
| 87 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67329266 |
| 88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67236509 |
| 89 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.65503829 |
| 90 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.63925318 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63347686 |
| 92 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.62848016 |
| 93 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.62690496 |
| 94 | Tuberculosis_Homo sapiens_hsa05152 | 0.62241213 |
| 95 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60350134 |
| 96 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.59686539 |
| 97 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.59221766 |
| 98 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58825124 |
| 99 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.58553028 |
| 100 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.58432596 |
| 101 | Prostate cancer_Homo sapiens_hsa05215 | 0.57751097 |
| 102 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.56998873 |
| 103 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.55834323 |
| 104 | Melanoma_Homo sapiens_hsa05218 | 0.55592424 |
| 105 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.55170145 |
| 106 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.54010977 |
| 107 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.53793721 |
| 108 | Influenza A_Homo sapiens_hsa05164 | 0.53450299 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52453528 |
| 110 | Salmonella infection_Homo sapiens_hsa05132 | 0.51176987 |
| 111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.50820714 |
| 112 | Renin secretion_Homo sapiens_hsa04924 | 0.50245102 |
| 113 | Thyroid cancer_Homo sapiens_hsa05216 | 0.49068859 |
| 114 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.47820990 |
| 115 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.47479516 |
| 116 | Insulin secretion_Homo sapiens_hsa04911 | 0.47410236 |
| 117 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.46833957 |
| 118 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46173668 |
| 119 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.45654926 |
| 120 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.45376345 |
| 121 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.45090906 |
| 122 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.44768482 |
| 123 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.44412570 |
| 124 | Lysine degradation_Homo sapiens_hsa00310 | 0.44345433 |
| 125 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.43872661 |
| 126 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.42833637 |
| 127 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.42717181 |
| 128 | Melanogenesis_Homo sapiens_hsa04916 | 0.41922860 |
| 129 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.41391690 |
| 130 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.41011387 |
| 131 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40560061 |
| 132 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.39628352 |
| 133 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39015284 |
| 134 | Carbon metabolism_Homo sapiens_hsa01200 | 0.38244613 |
| 135 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37889370 |
| 136 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.37467505 |
| 137 | Endocytosis_Homo sapiens_hsa04144 | 0.36408591 |
| 138 | Phagosome_Homo sapiens_hsa04145 | 0.36282577 |
| 139 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.36259436 |
| 140 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.35270430 |
| 141 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34752084 |
| 142 | Viral myocarditis_Homo sapiens_hsa05416 | 0.33477234 |
| 143 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.32324555 |
| 144 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.32015880 |
| 145 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.30583952 |
| 146 | Shigellosis_Homo sapiens_hsa05131 | 0.29990993 |
| 147 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.28675537 |
| 148 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.27172383 |
| 149 | Platelet activation_Homo sapiens_hsa04611 | 0.26969766 |

